TheraRadar
Data updated: Jul 17, 2026

MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER (milrinone lactate) · Baxter

Cardiovascular Approved 2002-05-28

MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER is FDA-approved to treat 1 condition (same as MILRINONE LACTATE).

6
Indications
--
Phase 3 Trials
24
Years on Market

Details

Status
Prescription
First Approved
2002-05-28
Routes
INJECTION
Dosage Forms
INJECTABLE

MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER Approval History

2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
21 FDA actions from 2002 to 2021
Jul 2021 SUPPL
Label · Labeling
Jul 2020 ORIGINAL
Update
May 2008 ORIGINAL
Update

What MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER Treats

1 indications

MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER is approved for 1 conditions since its original approval in 2002. These indications span multiple therapeutic areas including oncology, immunology, and more.

Same approved indications as MILRINONE LACTATE (same active ingredient).

Source: FDA Label
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER FDA Label Details

Indications & Usage

FDA Label (PDF)

MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER is FDA-approved to treat 1 condition — same approved indications as MILRINONE LACTATE.

Track MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.